Every day we conduct conversations with Cell Therapy experts from all over the world.
We would love for you to be one of them.
You can give us a call on (+1) 617 455 4188, or firstname.lastname@example.org
We endeavour to get back to all emails within 48 hours. We look forward to hearing from you.
To learn more about events in the Cell Therapy Series, visit:
Delivering Safer, More Effective & Globally Accessible Cell Therapies to Patients at Scale
Beacon's cell therapy database covers trial and drug records for preclinical, active, approved, and discontinued CAR (chimeric antigen receptor) modified therapies, TCR (T-Cell Receptor) therapies, natural killer cells, tumor-infiltrating lymphocytes cytokine-induced killer cells, dendritic cells, and macrophages.
A year-round experience-sharing and problem-solving network helping drug developers address critical R&D challenges in CAR-TCR therapies for solid tumors.
A trusted provider of market intelligence for anyone looking to understand the complexities of cell therapy research and development.